These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25215891)

  • 1. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
    Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
    Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
    Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
    Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
    Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
    Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective.
    Varra V; Ross RB; Juloori A; Campbell S; Tom MC; Joshi NP; Woody NM; Ward MC; Xia P; Koyfman SA; Greskovich JF
    Oral Oncol; 2019 Feb; 89():79-83. PubMed ID: 30732963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
    Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
    Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
    Robin TP; Gan GN; Tam M; Westerly D; Riaz N; Karam SD; Lee N; Raben D
    Head Neck; 2016 Apr; 38(4):506-11. PubMed ID: 25482748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Submandibular gland preservation during concurrent neck dissection and transoral surgery for oropharyngeal squamous cell carcinoma.
    Howard BE; Hinni ML; Nagel TH; Chang YH; Cheng MR; Hayden RE
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):587-93. PubMed ID: 24449797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.
    Rao AD; Coquia S; De Jong R; Gourin C; Page B; Latronico D; Dah S; Su L; Clarke S; Schultz J; Rosati LM; Fakhry C; Wong J; DeWeese TL; Quon H; Ding K; Kiess A
    Radiother Oncol; 2018 Jan; 126(1):96-99. PubMed ID: 28985953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma.
    Jackson WC; Hawkins PG; Arnould GS; Yao J; Mayo C; Mierzwa M
    Med Dosim; 2019 Summer; 44(2):144-149. PubMed ID: 29778321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perifacial lymph node metastasis in the submandibular triangle of patients with oral and oropharyngeal squamous cell carcinoma with clinically node-positive neck.
    Lim YC; Lee JS; Choi EC
    Laryngoscope; 2006 Dec; 116(12):2187-90. PubMed ID: 17146394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
    Vergeer MR; Doornaert PA; Jonkman A; Kaanders JH; van den Ende PL; de Jong MA; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):682-8. PubMed ID: 20188492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submandibular gland-sparing intensity-modulated radiotherapy.
    Mendenhall WM; Mendenhall CM; Mendenhall NP
    Am J Clin Oncol; 2014 Oct; 37(5):514-6. PubMed ID: 22892434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.